Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Corebridge Financial Inc.

Corebridge Financial Inc. increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 110,954 shares of the medical equipment provider’s stock after purchasing an additional 770 shares during the period. Corebridge Financial Inc.’s holdings in Intuitive Surgical were worth $57,914,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Atala Financial Inc bought a new stake in Intuitive Surgical during the fourth quarter valued at $25,000. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth about $26,000. BankPlus Trust Department bought a new position in Intuitive Surgical in the fourth quarter worth about $28,000. Kohmann Bosshard Financial Services LLC bought a new position in Intuitive Surgical during the 4th quarter worth $31,000. Finally, Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at $36,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $492.49 on Monday. The company has a market cap of $175.41 billion, a P/E ratio of 76.83, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm’s 50 day simple moving average is $562.24 and its 200-day simple moving average is $532.03.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on ISRG shares. Bernstein Bank lifted their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Stifel Nicolaus boosted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. BTIG Research upped their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Raymond James lifted their price target on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Finally, Wells Fargo & Company upped their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $611.86.

Insiders Place Their Bets

In related news, CFO Jamie Samath sold 94 shares of the stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the transaction, the vice president now directly owns 473 shares in the company, valued at approximately $271,397.94. This trade represents a 63.13 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 33,754 shares of company stock worth $17,691,621. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.